Amgen在波多黎各投资650M美元,以扩大生物逻辑生产,创造750个就业机会,加强美国毒品供应链。 Amgen invests $650M in Puerto Rico to expand biologics production, creating 750 jobs and strengthening U.S. drug supply chains.

Amgen公司正在投资6.5亿美元,以扩大其在波多黎各的生物制造设施,创造约750个新的就业机会。 Amgen Inc. is investing $650 million to expand its biologics manufacturing facility in Puerto Rico, creating around 750 new jobs. 升级的目的是提高生物药物的生产能力,加强公司的供应链,支持长期制造目标。 The upgrade aims to boost production capacity for biologic drugs, strengthen the company’s supply chain, and support long-term manufacturing goals. 该项目加强了该场址的基础设施以及先进的生产能力,加强了波多黎各在安根美国领土业务中的作用。 The project enhances the site’s infrastructure and advanced production capabilities, reinforcing Puerto Rico’s role in Amgen’s U.S. territory operations. 这一举动与扩大国内制药制造业的工业趋势相一致。 The move aligns with broader industry trends toward increasing domestic pharmaceutical manufacturing.